Sponsor
Novo Nordisk CEO to step down amid market challenges and stock plunge
Posted
Novo Nordisk's CEO, Lars Fruergaard Jorgensen, will step down amidst market challenges and a significant stock price drop, exceeding 50% since June 2024. Increased competition from compounded versions of Ozempic and Wegovy, along with Eli Lilly's Zepbound gaining market share, contributed to the decision.
Căutare
Categorii
- National
- International
- Business
- Technology
- Health
- Educaţie
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Citeste mai mult
Illegal remittance flows suspected in central bank Governor appointment: Koirala
KATHMANDU: Nepali Congress leader Dr. Shekhar Koirala has directly linked the suspected influx of...
At Arab summit, Spain calls for pressure on Israel to end Gaza 'massacre'
At an Arab League summit in Baghdad, global leaders urged increased pressure on Israel to halt...